Patent ID: 8394790
Filing Date: 2013-03-12
Classification: A61K,A61P,C07D

Abstract:
1. A compound, or a salt or stereoisomer thereof, of the formula L-M-V, wherein: L is olanzapine; M is optionally present and is a linker selected from the group consisting of —NH—, —O—, —S—, C V is a modulator of a glutamate N-methyl-D-aspartate (NMDA) receptor selected from the group consisting of an amino acid, an ester of the amino acid, an amide of the amino acid, and an alkylated amine of the amino acid; wherein said amino acid is selected from the group consisting of glycinyl, sarcosinyl, serinyl, and cysteinyl; and n, independently of each other, is an integer from 0 to 3.